Received Apr 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
received GARDASIL 9 at a younger age had a seizure; This spontaneous report was received from a physician via Company representative, concerning a female child patient. The patient's medical history, past medications, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On unspecified date (reported as "at a younger age"), the patient was vaccinated with human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) suspension for injection administered as prophylaxis (exact dose, dosage regimen, batch/lot#, expiration date, anatomical location and route of administration were not reported.) On an unknown date, when the patient received human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9), she had a seizure. At the reporting time, the patient was approximately 20-year-old (reported as "in her 20's"), and seizures had been resolved (recovered.) The causal relationship between seizure and human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) was not reported. Upon internal review, the event seizure was determined to be medically significant. This was one of three reports received from the same reporter.